The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System
Open accessAbstract
Myelin of the adult CNS is vulnerable to a variety of metabolic, toxic, and autoimmune insults. That remyelination can ensue, following demyelinating insult, has been well demonstrated. Details of the process of remyelination are, however difficult to ascertain since in most experimental models of demyelination/remyelination the severity, localization of lesion site, or time course of the pathophysiology is variable from animal to animal. In contrast, an experimental model in which massive demyelination can be reproducibly induced in large areas of mouse brain is exposure to the copper chelator, cuprizone, in the diet. We review work from several laboratories over the past 3 decades, with emphasis on our own recent studies, which suggest an overall picture of cellular events involved in demyelination/remyelination. When 8 week old C57BL/6 mice are fed 0.2% cuprizone in the diet, mature olidgodendroglia are specifically insulted (cannot fulfill the metabolic demand of support of vast amounts of myelin) and go through apoptosis.This is closely followed by recruitment of microglia and phagoctytosis of myelin. Studies of myelin gene expression, coordinated with morphological studies, indicate that even in the face of continued metabolic challenge, oligodendroglial progenitor cells proliferate and invade demyelinated areas. If the cuprizone challenge is terminated, an almost complete remyelination takes place in a matter of weeks. Communication between different cell types by soluble factors may be inferred. This material is presented in the context of a model compatible with present data—and which can be tested more rigorously with the cuprizone model. The reproducibility of the model indicates that it may allow for testing of manipulations (e.g. available knockouts or transgenics on the common genetic background, or pharmacological treatments) which may accelerate or repress the process of demyelination and or remyelination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The C57BL/6 mice showed a dramatic loss of myelin staining at this time point (Fig. 1b), which is consistent with previous reports [5].”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upon treatment with cuprizone, mice typically exhibit profound demyelination in the corpus callosum, the cortex and the superior cerebellar peduncles [4, 5].”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most investigators use the standard C57BL/6 mouse strain in the cuprizone model to study the different molecular components involved in the complex pathogenic processes leading to corpus callosum demyelination [5].”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the corpus callosum, apoptosis of oligodendrocytes is observed, together with recruitment of microglia/macrophages, astrocytes and oligodendrocyte progenitor cells (OPCs) [5, 6].”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, the continuous exposure of C57BL/6 mice to cuprizone results in a pattern of two cycles of demyelination and remyelination, followed by chronic demyelination from which animals do not recover 36, 39.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [39]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, C57BL/6 mice experience a spontaneous partial remyelination after 6 weeks and then continue to demyelinate further when exposed continuously to cuprizone 36, 39.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, unlike microglia and astrocytes in C57BL/6 mice that respond vigorously to demyelination 2, 23, 39, these cell types in SJL mice have a guarded response at midline and in the lateral region, which correlates with subdued demyelination.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cuprizone toxicity produces profound demyelination in the white and grey matter of the brain that mirrors sites of MS pathology [46].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other features common to both cuprizone-induced and type 3 MS lesions are mitochondrial stress, selective loss of myelin-associated glycoprotein (MAG), lesions with indistinct borders that are not perivascular, pronounced glial activation, and lymphocyte infiltration [43, 46, 65, 69–71].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The histopathological hallmark of the cuprizone model as standardized by Hiremath is oligodendrocyte death and subsequent demyelination in the corpus callosum, superior cerebellar peduncles, hippocampus [42, 46–54] and several other areas of the mouse brain (reviewed in [20]).”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglial activation and axonal loss positively correlate with demyelination and the reproducible lesion localization – primarily in the corpus callosum [186], cerebellar peduncle [186], hippocampus [187], and cortex [184, 185, 188] – mirrors the topographical specificity of MS pathology, including subpial cortical demyelination seen in PMS patients.”
From Insights and challenges on animal models for progressive multiple sclerosis (2026) · cites this paper as [186]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Remyelination is very robust in the cuprizone model and starts directly after demyelination is complete, irrespective if cuprizone is further fed or not (Matsushima and Morell, 2001; Hiremath et al., 2008; Gudi et al., 2009).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Matsushima and Morell, 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depletion of microglia likewise prevented the loss of oligodendrocytes (OLs) in the CC that normally results from CUP treatment (Matsushima & Morell, 2001).”
From Activated microglia drive demyelination via CSF1R signaling (2021) · cites this paper as Matsushima & Morell, 2001
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The cuprizone model involves administration of the toxin cuprizone to induce oligodendrocyte apoptosis [4, 5].”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Here, we explored the effect of antibody-mediated TREM2 activation on microglia in a well-established toxin-induced model of demyelination in the CNS resulting from exposure to the copper chelator cuprizone (CPZ) in the diet [31].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“These events lead to OPC recruitment, differentiation into mature OLs, and then remyelination which is almost complete within few weeks from toxin withdrawal [31].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [31]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It may suggest that NODDI could be sensitive biomarkers to probe the different stages of white matter pathology between acute demyelination and chronic demyelination (Matsushima and Morell 2001).”
From Neurite orientation dispersion and density imaging of mouse brain microstructure (2019) · cites this paper as Matsushima and Morell 2001
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Historically these cells are not linked to demyelination following cuprizone treatment because the loss of the V(D)J recombination activation gene-1 (RAG-1), which is critical for B- and T- lymphocyte generation [269], does not alter demyelination and T-cell accumulation in the corpus callosum [46, 270].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [46]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Demyelination peaks between 4.5 and 5 weeks of cuprizone exposure in the CC and between 5 and 6 weeks in the cortex and hippocampus (Hiremath et al., 1998; Matsushima and Morell, 2001; Skripuletz et al., 2008; Gudi et al., 2009; Koutsoudaki et al., 2009).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Matsushima and Morell, 2001
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Strong astrogliosis comprising hypertrophy and hyperplasia of astrocytes occurs as a response to cuprizone treatment in different white and gray matter structures for instance the CC (Matsushima and Morell, 2001; Gudi et al., 2009), hippocampus, (Koutsoudaki et al., 2009; Norkute et al., 2009), cerebellum, cortex (Skripuletz et al., 2008), and basal ganglia (Pott et al., 2009).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Matsushima and Morell, 2001
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Astrogliosis is an additional pathological hallmark of CUP treatment (Matsushima & Morell, 2001).”
From Activated microglia drive demyelination via CSF1R signaling (2021) · cites this paper as Matsushima & Morell, 2001
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice
Hiremath, M. M., Saito, Y., Knapp, G. W., Ting, J. P.-Y., Suzuki, K., & Matsushima, G. K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00168-4 · Cited by 412
Self-citation(1978) · PubMed · Cited by 297
Nishiyama, A., Lin, X., Giese, N. A., Heldin, C., & Stallcup, W. B. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960201)43:3 · Cited by 244
Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination
Mason, J. L., Ye, P., Suzuki, K., D'Ercole, A. J., & Matsushima, G. K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05703.2000 · Cited by 237
Self-citationKomoly, S., Hudson, L. D., Webster, H. D., & Bondy, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1894 · Cited by 223
Blakemore, W. F. (1972) · Journal of Neurocytology · doi:10.1007/bf01102943 · Cited by 217
Gene Expression in Brain during Cuprizone-Induced Demyelination and Remyelination
Morell, P., Barrett, C. V., Mason, J. L., Toews, A. D., Hostettler, J. D., Knapp, G. W., & Matsushima, G. K. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0715 · Cited by 213
Self-citationDemyelination of the superior cerebellar peduncle in the mouse induced by cuprizone
Blakemore, W. F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90118-4 · Cited by 207
Blakemore, W. F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90119-6 · Cited by 177
Research works printed but not linked: 2
- Jurevics HA, 2000, Lipid metabolism during remyelination in brain, J Neurochem, 74, S32
- Ludwin SK, 1980, Chronic demyelination inhibits remyelination in the central nervous system, Lab Invest, 43, 382
Cited by
Sorted by citations
Items 101–200 of 985
Binder, M. D., Cate, H. S., Prieto, A. L., Kemper, D., Butzkueven, H., Gresle, M. M., Cipriani, T., Jokubaitis, V. G., Carmeliet, P., & Kilpatrick, T. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1180-08.2008 · Cited by 138
Lesion stage-dependent causes for impaired remyelination in MS
Heß, K., Starost, L. J., Kieran, N. W., Thomas, C., Vincenten, M. C. J., Antel, J. P., Martino, G., Huitinga, I., Healy, L. M., & Kuhlmann, T. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02189-9 · Cited by 144
Shen, K., Reichelt, M., Kyauk, R. V., Ngu, H., Shen, Y.-A. A., Foreman, O., Modrusan, Z., Friedman, B. A., Sheng, M., & Yuen, T. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108835 · Cited by 138
Cytokines and Myelination in the Central Nervous System
Schmitz, T., & Chew, L. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.140 · Cited by 141
Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone.
Xu, H., Yang, H.-J., Zhang, Y., Clough, R., Browning, R., & Li, X.-M. (2009) · Behavioral Neuroscience · doi:10.1037/a0014477 · Cited by 137
Chen, M., Baidoo, K. E., Verina, T., & Guilarte, T. R. (2004) · Brain · doi:10.1093/brain/awh161 · Cited by 140
Lindner, M., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.004 · Cited by 136
Patel, J. R., Williams, J. L., Muccigrosso, M. M., Liu, L., Sun, T., Rubin, J. B., & Klein, R. S. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1034-0 · Cited by 134
Wolf, Y., Shemer, A., Levy‐Efrati, L., Gross, M., Kim, J., Engel, A., David, E., Chappell‐Maor, L., Grozovski, J., Rotkopf, R., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847540 · Cited by 129
Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI
Boretius, S., Escher, A., Dallenga, T., Wrzos, C., Tammer, R., Brück, W., Nessler, S., Frahm, J., & Stadelmann, C. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.051 · Cited by 128
A New Model of Cuprizone-Mediated Demyelination/Remyelination
Sachs, H. H., Bercury, K. K., Popescu, D. C., Narayanan, S. P., & Macklin, W. B. (2014) · ASN NEURO · doi:10.1177/1759091414551955 · Cited by 128
Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: An ongoing story
Caminero, A. B., Comabella, M., & Montalbán, X. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.03.004 · Cited by 126
Differentiation of induced pluripotent stem cells into functional oligodendrocytes
Czepiel, M., Balasubramaniyan, V., Schaafsma, W., Stančić, M., Mikkers, H., Huisman, C., Boddeke, E., & Copray, S. (2011) · Glia · doi:10.1002/glia.21159 · Cited by 134
Remyelinating strategies for the treatment of multiple sclerosis
Stangel, M., & Hartung, H.-P. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00105-3 · Cited by 126
Endogenous cell repair of chronic demyelination
Armstrong, R. C., Le, T. Q., Flint, N. C., Vana, A. C., & Zhou, Y.-X. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000205142.08716.7e · Cited by 125
Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination
Hibbits, N., Yoshino, J., Le, T. Q., & Armstrong, R. C. (2012) · ASN Neuro · doi:10.1042/an20120062 · Cited by 125
Neuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons
Duncan, G. J., Simkins, T., & Emery, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653101 · Cited by 131
Taylor, L. C., Gilmore, W., Ting, J. P. ‐., & Matsushima, G. K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22215 · Cited by 123
Self-citationClemente, D., Ortega, M. C., Melero‐Jerez, C., & de Castro, F. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00268 · Cited by 131
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus
Norkute, A., Hieble, A., Braun, A., Johann, S., Clarner, T., Baumgartner, W., Beyer, C., & Kipp, M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21946 · Cited by 123
Interferon regulatory factor 7 participates in the M 1‐like microglial polarization switch
Tanaka, T., Murakami, K., Bandô, Y., & Yoshida, S. (2014) · Glia · doi:10.1002/glia.22770 · Cited by 123
Bojar, M. (2009) · Cited by 120
Demyelination of the hippocampus is prominent in the cuprizone model
Koutsoudaki, P. N., Skripuletz, T., Gudi, V., Moharregh-Khiabani, D., Hildebrandt, H., Trebst, C., & Stangel, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.058 · Cited by 119
Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review
Sheykhansari, S., Kozielski, K., Bill, J., Sitti, M., Gemmati, D., Zamboni, P., & Singh, A. V. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0379-2 · Cited by 124
Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse
Zhang, Y., Xu, H., Jiang, W., Xiao, L., Yan, B., He, J., Wang, Y., Bi, X., Li, X., & Kong, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.013 · Cited by 121
Irvine, K.-A., & Blakemore, W. F. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.002 · Cited by 117
Probing mouse brain microstructure using oscillating gradient diffusion MRI
Aggarwal, M., Jones, M. V., Calabresi, P. A., Mori, S., & Zhang, J. (2012) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22981 · Cited by 117
El-Etr, M., Rame, M., Boucher, C., Ghoumari, A. M., Kumar, N., Liere, P., Pianos, A., Schumacher, M., & Sitruk-Ware, R. (2015) · Glia · doi:10.1002/glia.22736 · Cited by 116
Groebe, A., Clarner, T., Baumgartner, W., Dang, J., Beyer, C., & Kipp, M. (2009) · The Cerebellum · doi:10.1007/s12311-009-0099-3 · Cited by 116
Copray, S. C. V. M., Balasubramaniyan, V., Levenga, J., de Bruijn, J., Liem, R. S. B., & Boddeke, E. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0239 · Cited by 117
Elbaz, E. M., Senousy, M. A., El-Tanbouly, D. M., & Sayed, R. H. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.05.035 · Cited by 115
Remyelination alters the pattern of myelin in the cerebral cortex
Orthmann-Murphy, J., Call, C. L., Molina-Castro, G. C., Hsieh, Y. C., Rasband, M. N., Calabresi, P. A., & Bergles, D. E. (2020) · eLife · doi:10.7554/elife.56621 · Cited by 111
Hibbits, N., Pannu, R., Wu, T. J., & Armstrong, R. C. (2009) · ASN Neuro · doi:10.1042/an20090032 · Cited by 111
Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis
Kipp, M., & Beyer, C. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.004 · Cited by 116
Xu, H. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00008 · Cited by 108
Mingorance, A., Fontana, X., Solé, M., Burgaya, F., Ureña, J. M., Teng, F. Y. H., Tang, B. L., Hunt, D. P. J., Anderson, P. N., Bethea, J. R., et al. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.01.001 · Cited by 107
Cerebellar Cortical Demyelination in the Murine Cuprizone Model
Skripuletz, T., Bussmann, J., Gudi, V., Koutsoudaki, P. N., Pul, R., Moharregh‐Khiabani, D., Lindner, M., & Stangel, M. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00271.x · Cited by 108
Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation
Rowin, J. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.046987 · Cited by 108
Late motor decline after accomplished remyelination: Impact for progressive multiple sclerosis
Manrique‐Hoyos, N., Jürgens, T., Grønborg, M., Kreutzfeldt, M., Schedensack, M., Kuhlmann, T., Schrick, C., Brück, W., Urlaub, H., Simons, M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22681 · Cited by 107
Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death
Veto, S., Acs, P., Bauer, J., Lassmann, H., Berente, Z., Setalo, G., Borgulya, G., Sumegi, B., Komoly, S., Gallyas, F., et al. (2010) · Brain · doi:10.1093/brain/awp337 · Cited by 107
Raasch, J., Zeller, N., van Loo, G., Merkler, D., Mildner, A., Erny, D., Knobeloch, K.-P., Bethea, J. R., Waisman, A., Knust, M., et al. (2011) · Brain · doi:10.1093/brain/awq359 · Cited by 106
Jurevics, H., Largent, C., Hostettler, J., Sammond, D. W., K. Matsushima, G., Amber Kleindienst, Toews, A. D., & Morell, P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00954.x · Cited by 106
Self-citationDemyelination and inhibition of tumor necrosis factor (TNF).
Magnano, M. D., Robinson, W. H., & Genovese, M. C. (2004) · PubMed · Cited by 105
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond
Kipp, M., van der Star, B. J., Vogel, D. Y. S., Puentes, F., van der Valk, P., Baker, D., & Amor, S. (2011) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2011.09.002 · Cited by 116
Neuronal nitric oxide synthase plays a key role in CNS demyelination
Liñares, D., Taconis, M., Maña, P., Correcha, M., Fordham, S., Staykova, M., & Willenborg, D. O. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0294-06.2006 · Cited by 105
The unfolded protein response in multiple sclerosis
Stone, S., & Lin, W. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00264 · Cited by 105
Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons
Ohno, N., Chiang, H., Mahad, D., Kidd, G. J., Liu, L., Ransohoff, R. M., Sheng, Z., Komuro, H., & Trapp, B. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401155111 · Cited by 109
Baxi, E. G., DeBruin, J., Tosi, D. M., Grishkan, I. V., Smith, M. D., Kirby, L. A., Strasburger, H. J., Fairchild, A. N., Calabresi, P. A., & Gocke, A. R. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3817-14.2015 · Cited by 103
Gudi, V., Škuljec, J., Yildiz, Ö., Frichert, K., Skripuletz, T., Moharregh-Khiabani, D., Voß, E., Wissel, K., Wolter, S., & Stangel, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022623 · Cited by 103
Bédard, A., Tremblay, P., Chernomoretz, A., & Vallières, L. (2007) · Glia · doi:10.1002/glia.20477 · Cited by 103
The significance of copper chelators in clinical and experimental application
Ding, X., Xie, H., & Kang, Y. J. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.06.010 · Cited by 102
Καραμίτα, Μ., Barnum, C. J., Möbius, W., Tansey, M. G., Szymkowski, D. E., Lassmann, H., & Probert, L. (2017) · JCI Insight · doi:10.1172/jci.insight.87455 · Cited by 103
Axon‐oligodendrocyte interactions during developmental myelination, demyelination and repair
Piaton, G., Gould, R. M., & Lubetzki, C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06831.x · Cited by 107
Multicontrast MRI of remyelination in the central nervous system
Merkler, D., Boretius, S., Stadelmann, C., Ernsting, T., Michaelis, T., Frahm, J., & Brück, W. (2005) · NMR in Biomedicine · doi:10.1002/nbm.972 · Cited by 102
Platelet-Derived Growth Factor Promotes Repair of Chronically Demyelinated White Matter
Vana, A. C., Flint, N. C., Harwood, N. E., Le, T. Q., Fruttiger, M., & Armstrong, R. C. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181587d46 · Cited by 101
Behavioural phenotypes in the cuprizone model of central nervous system demyelination
Sen, M. K., Mahns, D. A., Coorssen, J. R., & Shortland, P. J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.008 · Cited by 101
In toxic demyelination oligodendroglial cell death occurs early and is FAS independent
Hesse, A., Wagner, M., Held, J., Brück, W., Salinas-Riester, G., Hao, Z., Waisman, A., & Kuhlmann, T. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.016 · Cited by 98
Kuhlmann, T., Remington, L. T., Maruschak, B., Owens, T., & Brück, W. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000248559.83573.71 · Cited by 98
Plemel, J. R., Caprariello, A. V., Keough, M. B., Henry, T. J., Tsutsui, S., Chu, T. H., Schenk, G. J., Klaver, R., Yong, V. W., & Stys, P. K. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201602028 · Cited by 97
Baxi, E. G., DeBruin, J., Jin, J., Strasburger, H. J., Smith, M. D., Orthmann‐Murphy, J. L., Schott, J. T., Fairchild, A. N., Bergles, D. E., & Calabresi, P. A. (2017) · Glia · doi:10.1002/glia.23229 · Cited by 97
Functional recovery of callosal axons following demyelination: A critical window
Crawford, D. K., Mangiardi, M., Xia, X., López-Valdés, H. E., & Tiwari-Woodruff, S. K. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.09.069 · Cited by 97
Negative Impact of Statins on Oligodendrocytes and Myelin Formation In Vitro and In Vivo
Klopfleisch, S., Merkler, D., Schmitz, M., Klöppner, S., Schedensack, M., Jeserich, G., Althaus, H. H., & Brück, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2765-08.2008 · Cited by 97
Rajan, W. D., Wojtaś, B., Gielniewski, B., Gieryng, A., Zawadzka, M., & Kaminska, B. (2018) · Glia · doi:10.1002/glia.23536 · Cited by 97
Khodanovich, M. Y., Sorokina, I. V., Glazacheva, V., Евгеньевич, А. А., Nemirovich-Danchenko, N. M., Romashchenko, A. V., Tolstikova, T. G., Mustafina, L. R., & Yarnykh, V. L. (2017) · Scientific Reports · doi:10.1038/srep46686 · Cited by 97
Falangola, M. F., Guilfoyle, D. N., Tabesh, A., Hui, E. S., Nie, X., Jensen, J. H., Gerum, S. V., Hu, C., LaFrancois, J., Collins, H. R., et al. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3140 · Cited by 96
Suo, N., Guo, Y., He, B., Gu, H., & Xie, X. (2019) · Glia · doi:10.1002/glia.23606 · Cited by 96
Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice
Hoffmann, K., Lindner, M., Gröticke, I., Stangel, M., & Löscher, W. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.005 · Cited by 93
Celarain, N., & Tomàs-Roig, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1667-1 · Cited by 90
Ammar, R. A., Mohamed, A. F., Kamal, M. M., Safar, M. M., & Abdelkader, N. F. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00956-6 · Cited by 93
Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin
Adamo, A. M., Paez, P. M., Cabrera, O. E. E., Wolfson, M. L., Franco, P. G., Pasquini, J. M., & Soto, E. F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.027 · Cited by 89
Siebert, J. R., Stelzner, D. J., & Osterhout, D. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.002 · Cited by 90
Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model
Wergeland, S., Torkildsen, Ø., Myhr, K.-M., Aksnes, L., Mørk, S. J., & Bø, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026262 · Cited by 88
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
Shafit‐Zagardo, B., Gruber, R. C., & DuBois, J. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.002 · Cited by 89
Zhang, J., Jones, M. V., McMahon, M. T., Mori, S., & Calabresi, P. A. (2012) · Magnetic Resonance in Medicine · doi:10.1002/mrm.23032 · Cited by 88
Mitochondria in Multiple Sclerosis: Molecular Mechanisms of Pathogenesis
Patergnani, S., Fossati, V., Bonora, M., Giorgi, C., Marchi, S., Missiroli, S., Rusielewicz, T., Wieckowski, M. R., & Pinton, P. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.003 · Cited by 86
Ji, E., Guevara, P., Guevara, M., Grigis, A., Labra, N., Sarrazin, S., Hamdani, N., Bellivier, F., Delavest, M., Leboyer, M., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz015 · Cited by 84
Marriott, M. P., Emery, B., Cate, H. S., Binder, M. D., Kemper, D., Wu, Q., Kolbe, S., Gordon, I. R., Wang, H., Egan, G., et al. (2008) · Glia · doi:10.1002/glia.20646 · Cited by 86
Hou, J., Zhou, Y., Cai, Z., Terekhova, M., Swain, A., Andhey, P. S., Guimaraes, R. M., Ulezko Antonova, A., Qiu, T., Sviben, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112293 · Cited by 85
Myelin Repair Is Accelerated by Inactivating CXCR2 on Nonhematopoietic Cells
Liu, L., Darnall, L., Hu, T., Choi, K., Lane, T. E., & Ransohoff, R. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1238-10.2010 · Cited by 85
Guglielmetti, C., Najac, C., Didonna, A., der Linden, A. V., Ronen, S. M., & Chaumeil, M. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613345114 · Cited by 83
Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia
Pott, F., Gingele, S., Clarner, T., Dang, J., Baumgartner, W., Beyer, C., & Kipp, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.084 · Cited by 85
Taylor, L. C., Gilmore, W., & Matsushima, G. K. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00230.x · Cited by 84
Self-citationCopper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment
Zatta, P., Raso, M., Zambenedetti, P., Wittkowski, W., Messori, L., Piccioli, F., Mauri, P. L., & Beltramini, M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5073-8 · Cited by 84
Acs, P., Selak, M. A., Komoly, S., & Kalman, B. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.06.012 · Cited by 84
Croxford, J. L., OLSON, J., & MILLER, S. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00080-0 · Cited by 84
Chari, D. M., Crang, A. J., & Blakemore, W. F. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.908 · Cited by 84
Targeting sonic hedgehog signaling in neurological disorders
Patel, S. S., Tomar, S., Sharma, D., Mahindroo, N., & Malairaman, U. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.008 · Cited by 86
Turati, L., Moscatelli, M. E. M., Mastropietro, A., Dowell, N. G., Zucca, I., Erbetta, A., Cordiglieri, C., Brenna, G., Bianchi, B., Mantegazza, R., et al. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3253 · Cited by 84
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination
Caprariello, A. V., Mangla, S., Miller, R. H., & Selkirk, S. M. (2012) · Annals of Neurology · doi:10.1002/ana.23606 · Cited by 87
Wu, Q., Yang, Q., Cate, H. S., Kemper, D., Binder, M. D., Wang, H., Fang, K., Quick, M. J., Marriott, M. P., Kilpatrick, T. J., et al. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21111 · Cited by 86
Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte Injury
Kim, S.-J., Steelman, A. J., Zhang, Y., Kinney, H. C., & Li, J. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00501.x · Cited by 82
Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease
Stumpf, S. K., Berghoff, S. A., Trevisiol, A., Spieth, L., Düking, T., Schneider, L. V., Schlaphoff, L., Dreha‐Kulaczewski, S. F., Bley, A. E., Burfeind, D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01985-2 · Cited by 83
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination
Kang, Z., Liu, L., Spangler, R., Spear, C., Wang, C., Gulen, M. F., Veenstra, M., Ouyang, W., Ransohoff, R. M., & Li, X. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0841-12.2012 · Cited by 78
Selective vulnerability of inhibitory networks in multiple sclerosis
Zoupi, L., Booker, S. A., Eigel, D., Werner, C., Kind, P. C., Spires‐Jones, T. L., Newland, B., & Williams, A. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02258-z · Cited by 78
Silvestroff, L., Bartucci, S. L., Pasquini, J. M., & Franco, P. G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.02.018 · Cited by 77
Pak, K. J., Chan, S. L., & Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:1:53 · Cited by 78
Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology
de Castro, F., Bribián, A., & Ortega, M. C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1365-6 · Cited by 83
Hübner, N. S., Mechling, A. E., Lee, H., Reisert, M., Bienert, T., Hennig, J., von Elverfeldt, D., & Harsan, L. A. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.11.008 · Cited by 75
Alizadeh, A., Dyck, S. M., Kataria, H., Shahriary, G. M., Nguyen, D. H., Santhosh, K. T., & Karimi‐Abdolrezaee, S. (2017) · Glia · doi:10.1002/glia.23150 · Cited by 80
Guglielmetti, C., Le Blon, D., Santermans, E., Salas-Perdomo, A., Daans, J., De Vocht, N., Shah, D., Hoornaert, C., Praet, J., Peerlings, J., et al. (2016) · Glia · doi:10.1002/glia.23053 · Cited by 76
Metadata
- Authors
- Matsushima, G. K., & Morell, P.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Matsushima, Glenn K.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 11
- Issue
- 1
- Pages
- 107-116
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- PMC
- PMC8098267
- OpenAlex
- W2100904149
- Cited by
- 984
- References
- 45
- Citations by year
- 2026: 31 · 2025: 38 · 2024: 42 · 2023: 50 · 2022: 58 · 2021: 48 · 2020: 55 · 2019: 75 · 2018: 59 · 2017: 65 · 2016: 39 · 2015: 58 · 2014: 39 · 2013: 53 · 2012: 40
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns011615-29, 5r01ns037815-05, 5r29ns035372-05)
- National Institute of Neurological Disorders and Stroke (NS37815, NS-11615, NS-35372)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- cuprizone, demyelination, remyelination, oligodendrocyte apoptosis, microglia, myelin phagocytosis, oligodendrocyte precursor cells, myelin gene expression, C57BL/6 mice, copper chelators
- MeSH terms
- Animals, Central Nervous System, Chelating Agents, Cuprizone, Demyelinating Diseases, Mice, Inbred C57BL, Myelin Sheath, Oligodendroglia, Microglia, Models, Animal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
